Felicia Norwood Net Worth

The estimated Net Worth of Felicia F Norwood is at least $8.03 Milione dollars as of 1 August 2022. Ms. Norwood owns over 98 units of Anthem Inc stock worth over $110,028 and over the last 6 years she sold ANTM stock worth over $0. In addition, she makes $7,922,760 as Executive Vice President e President - Government Business Division at Anthem Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Norwood ANTM stock SEC Form 4 insiders trading

Felicia has made over 1 trades of the Anthem Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she bought 98 units of ANTM stock worth $3,095 on 1 August 2022.

The largest trade she's ever made was buying 98 units of Anthem Inc stock on 1 August 2022 worth over $3,095. On average, Felicia trades about 5 units every 0 days since 2018. As of 1 August 2022 she still owns at least 228 units of Anthem Inc stock.

You can see the complete history of Ms. Norwood stock trades at the bottom of the page.

Felicia Norwood biography

Felicia F. Norwood serves as Executive Vice President, President - Government Business Division of the Company. Prior to joining us, she was Director of The Department of Healthcare and Family Services for the State of Illinois from January 2015 to June 2018. Prior to that appointment, Ms. Norwood served as President of the Mid-America Region for Aetna, Inc. (health insurance) from January 2010 until May 2013.

What is the salary of Felicia Norwood?

As the Executive Vice President e President - Government Business Division of Anthem Inc, the total compensation of Felicia Norwood at Anthem Inc is $7,922,760. There are 1 executives at Anthem Inc getting paid more, with Gail Boudreaux having the highest compensation of $15,473,100.

How old is Felicia Norwood?

Felicia Norwood is 60, she's been the Executive Vice President e President - Government Business Division of Anthem Inc since 2018. There are 12 older and 10 younger executives at Anthem Inc. The oldest executive at Anthem Inc is Julie Hill, 73, who is the Independent Director.

Insiders trading at Anthem Inc

Over the last 10 years, insiders at Anthem Inc have traded over $153,319,533 worth of Anthem Inc stock and bought 10,600 units worth $3,007,039 . The most active insiders traders include Antonio F Neri, Ryan M. Schneider e Lewis Iii Hay. On average, Anthem Inc executives and independent directors trade stock every 21 days with the average trade being worth of $5,250,953. The most recent stock trade was executed by Charles Morgan Jr Kendrick on 9 June 2022, trading 6,328 units of ANTM stock currently worth $1,806,771.

What does Anthem Inc do?

Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately 43 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner.

Complete history of Ms. Norwood stock trades at Anthem Inc, Hill-Rom Inc e Wells Fargo & Co

Anthem Inc executives and stock owners

Anthem Inc executives and other stock owners filed with the SEC include:

• Gail Boudreaux,
  President, Chief Executive Officer, Director
• Felicia Norwood,
  Executive Vice President, President - Government Business Division
• Gloria McCarthy,
  Executive Vice President, Chief Administrative Officer
• Gail Koziara Boudreaux,
  Pres, CEO & Director
• John Gallina,
  Chief Financial Officer, Executive Vice President
• Peter Haytaian,
  Executive Vice President, President of Commercial and Specialty Business Division
• Thomas Zielinski,
  Executive Vice President, General Counsel
• John Edward Gallina,
  Exec. VP & CFO
• Gloria Marie McCarthy,
  Exec. VP and Chief Admin. Officer
• Peter David Haytaian Esq.,
  Exec. VP and Pres of Diversified Bus. & IngenioRx
• Felicia Farr Norwood,
  Exec. VP & Pres of Gov. Bus. Division
• Elizabeth Tallett,
  Independent Chairman of the Board
• Ramiro Peru,
  Independent Director
• Julie Hill,
  Independent Director
• Robert Dixon,
  Independent Director
• Lewis Hay,
  Independent Director
• R. Kerry Clark,
  Independent Director
• Antonio Neri,
  Independent Director
• Bahija Jallal,
  Independent Director
• Ryan Schneider,
  Independent Director
• Chris Rigg,
  Vice President Investor Relations
• Ronald Penczek,
  Senior Vice President, Chief Accounting Officer, Controller
• Prakash Patel,
  Executive Vice President, President - Diversified Business Group
• Leah Stark,
  Chief Human Resource Officer, Executive Vice President
• Stephen Vartan Tanal C.F.A.,
  VP of Investor Relations
• Thomas H. Miller,
  Sr. VP & Chief Information Officer
• Anil Bhatt,
  Chief Technology Officer
• Ronald William Penczek,
  Sr. VP, Controller & Chief Accounting Officer
• Scott Wayne Anglin,
  SVP, Treasurer & Chief Investment Officer
• Joseph Swedish,
  President & CEO
• William J Ryan,
  Director
• George A Jr Schaefer,
  Director
• Jose D. Tomas,
  EVP & Chief HR Officer
• Jacquelyn H Wolf,
  EVP & Chief HR Officer
• Craig E Samitt,
  EVP & Chief Clinical Officer
• Wayne S De Veydt,
  EVP & Chief Financial Officer
• Brian T Griffin,
  EVP & President, CSBD
• Samuel R Md Nussbaum,
  EVP & Chief Medical Officer
• Martin B Silverstein,
  EVP & Chief Strategy Officer
• Kenneth R Goulet,
  EVP, Commercial & Specialty
• Blair Williams Todt,
  EVP and Chief Legal Officer
• Jeffrey D. Alter,
  EVP, IngenioRx & Anthem Health
• Susan D. De Vore,
  Director
• Charles Morgan Jr Kendrick,
  EVP & President, Commercial